Top Markets
Coin of the day
OS Therapies Incorporated OS Therapies Incorporated

OS Therapies Incorporated

OSTX
Rank in Stocks #23564
OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses... OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. Its pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and OST-tunable drug conjugate (OST-tADC), an antibody-drug conjugate (ADC) silicone dioxide linker technology, with a plug-and-play platform that features tunable pH sensitive silicone linkers. OS Therapies Incorporated was incorporated in 2018 and is based in Grasonville, Maryland.
Share Price
$1.58
Last synced: 2026-08-21
Market Cap
$71.95M
Change (1 day)
0.64%
Change (1 year)
-36.29%
Country
US
Trade OS Therapies Incorporated (OSTX)

Category

P/B ratio for OS Therapies Incorporated (OSTX)
P/B ratio as of 2026 TTM: 0
According to OS Therapies Incorporated latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for OS Therapies Incorporated from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors
Company P/B Ratio P/B Ratio Difference Country
6.3419 -
US
6.2413 -
NL
3.7087 -
US
2.5054 -
AU
- -
CH